DanielCarpenterBelzMD
Pulmonology • Baltimore, MDAsthma & COPD, Critical Care Medicine
Assistant Professor of Medicine, Johns Hopkins University School of Medicine
Dr. Belz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5501 Hopkins Bayview Circle
Baltimore, MD 21224- Is this information wrong?
Summary
- Dr. Belz is a pulmonologist in Baltimore, MD and is affiliated with the Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He is the director of bronchiectasis at the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis and a member of the Johns Hopkins Breathe Center, which is dedicated to studying the effects of environment on lung health and specific lung diseases throughout life. He specializes in pulmonary and critical care medicine and is experienced in bronchiectasis, chronic obstructive pulmonary disease (COPD), critical care medicine, and nontuberculous mycobacteria. He received his medical degree and master of public health from the University of Kansas School of Medicine, completed internal medicine residency and chief residency at Boston University, and fellowship in pulmonary and critical care medicine at Johns Hopkins University.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2022
Boston University Medical CenterResidency, Internal Medicine, 2014 - 2017
University of Kansas School of MedicineClass of 2014
Certifications & Licensure
MD State Medical License 2019 - 2024
MA State Medical License 2014 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Higher Plasma Omega-3 Levels are Associated With Improved Exacerbation Risk and Respiratory-Specific Quality of Life in COPD.Tyus A Kemper, Han Woo, Wendy Lorizio, Michelle N Eakin, Emily P Brigham, Corrine Hanson, Daniel Belz, Ashraf Fawzy, Nirupama Putcha, Meredith C McCormack, Abigail L K...> ;Chronic Obstructive Pulmonary Diseases. 2024 Apr 22
- Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.Binayak Rimal, Chandra M Panthi, Yi Xie, Daniel C Belz, Elisa H Ignatius, Christopher K Lippincott, Daniel H Deck, Alisa W Serio, Gyanu Lamichhane> ;Tuberculosis. 2024 May 1
- Indoor particulate matter concentrations and air cleaner intervention association with biomarkers in former smokers with COPD.Woo, H., Kohler, K., Fawzy, A., Raju, S., Belz, D., Putcha, N., Williams, M., McCormack, M., Hansel, N.> ;Environmental Research. 2024 Feb 15
- Join now to see all
Press Mentions
Chronic Obstructive Pulmonary Diseases: Journal of the COPD FoundationMay 6th, 2024- Chronic Obstructive Pulmonary Diseases: Journal of the COPD FoundationNovember 17th, 2023
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
